A recent report published by Infinium Global Research on minimally invasive glaucoma surgery (MIGS) devices market provides an in-depth analysis of segments and sub-segments in the global as well as regional minimally invasive glaucoma surgery devices market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional minimally invasive glaucoma surgery devices market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global minimally invasive glaucoma surgery devices market. According to the report, the global minimally invasive glaucoma surgery devices market is projected to grow at a CAGR of 24.6% over the forecast period of 2019-2025.
The development of minimally invasive glaucoma surgery devices has changed patient care with mild-to-moderate glaucoma conditions. Minimally Invasive Glaucoma Surgery (MIGS) is a surgical procedure performed on patients suffering from glaucoma. MIGS is a safer and effective surgery as compared to conventional open surgery or laser surgery. Unlike conventional surgeries, MIGS is associated with lesser risks. The microscopic tools and equipment that are administered through lesser invasive means in the glaucoma treatment are known as MIGS devices. MIGS devices come in various forms including stents, shunts and other forms.
Factors such as the increase in the geriatric population, rise in the prevalence of ophthalmic disorders and subsequent blindness are the major drivers for the global MIGS devices market. Cataract and glaucoma are the two most prevailing eye-diseases that arise with growing age, which are one of the major causes of blindness in the aged population. Moreover, increasing demand for combined glaucoma and cataract treatment due to technological advancement in devices and growing awareness about minimally invasive surgeries among the patients are factors pushing the growth of MIGS devices market further. Additionally, the major players in the ophthalmic treatment market are more focused on developing MIGS stent for more effective treatment. This in return is expected to boost the demand for MIGS devices. However, poor reimbursement scenario and the dearth of experienced and skilled professionals are some of the factors that may hinder the growth of the global MIGS devices market. Nevertheless, the trend in glaucoma therapy is been observed to shift from conventional medication to minimally invasive surgeries, which is anticipated to provide lucrative opportunities to the companies in the MIGS devices market.
Geographically, the global MIGS devices market is divided into four major regions including, North America, Europe, Asia Pacific and the Rest of the World. The North American region dominated the global MIGS devices market accounting for the highest market share. The large share of the North American region attributes to the increase in the geriatric population, availability of better healthcare infrastructure and the presence of key players in the market. However, the market in the Asia Pacific region registered the fastest growth rate owing to the large population base suffering from ophthalmic diseases, growing demand for minimally invasive surgeries and a rise in the government expenditure on healthcare.
The report on global minimally invasive glaucoma surgery devices market covers segments such as surgery, target, product, and end-users. On the basis of surgery, the sub-markets include glaucoma in conjunction with cataract, and stand alone glaucoma. On the basis of target, the sub-markets include trabecular meshwork, suprachoroidal space, and other targets. On the basis of product, the sub-markets include MIGS stents, MIGS shunts, and other products. On the basis of end-users, the sub-markets include hospitals, ophthalmology clinics, and ambulatory surgical centers.
The report provides profiles of the companies in the market such as Alcon Vision LLC, Allergan PLC, Bausch & Lomb Inc, Carl Zeiss Meditec, Inc., Ellex Medical Lasers Ltd, Glaukos Corp, Ivantis, Inc., Lumenis Ltd., Santen Pharmaceutical Co., Ltd., and SOLX, Inc.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of minimally invasive glaucoma surgery devices market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter